About Embecta Corp. 
Embecta Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 68 Schemes (52.7%)
Foreign Institutions
Held by 134 Foreign Institutions (9.68%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
272 Million
(Quarterly Results - Jun 2026)
Net Profit:
21 Million
Pharmaceuticals & Biotechnology
USD 508 Million (Micro Cap)
3.00
NA
6.87%
-1.91
-999,999.00%
-0.83






